Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 4, 2002, Pages 541-545

  Perez, S ^a   Solans, C ^b   Bregante, M A ^b   Pinilla, I ^a   Garcia M A ^b   Honrubia, F ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; GENTAMICIN; GREPAFLOXACIN; IMIPENEM; LOMEFLOXACIN; OFLOXACIN; PENTOBARBITAL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBENICILLIN; TROVAFLOXACIN; VANCOMYCIN;

ALBINISM; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORNEA; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG PENETRATION; EYE INFECTION; IRIS; NONHUMAN; RABBIT; RETINA; STATISTICAL SIGNIFICANCE; STEADY STATE;

EID: 0036799037     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf178     Document Type: Article

References (35)

1. Cochereau-Massin, I., Bauchet, J., Faurisson, F., Vallois, J. M., Lacombe, P. & Pocidalo, J. J. (1991). Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits. Antimicrobial Agents and Chemotherapy 35, 1112-5.
2. Hamel, B., Mottet, N., Audran, M., Costa, P. & Bressolle, F. (2000). Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue. Journal of Antimicrobial Chemotherapy 46, 993-6.
3. Gee, T., Andrews, J. M., Ashby, J. P., Marshall, G. & Wise, R. (2001). Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose. Journal of Antimicrobial Chemotherapy 47, 431-4.
4. McKellar, Q., Gibson, I., Monteiro, A. & Bregante, M. A. (1999). Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy 43, 1988-92.
5. Bregante, M. A., Saez, P., Aramayona, J. J., Fraile, L., Garcia, M. A. & Solans, C. (1999). Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. American Journal of Veterinary Research 60, 1111-6.
6. Garcia, M. A., Solans, C., Aramayona, J. J., Rueda, S. & Bregante, M. A. (2000). Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection. Biomedical Chromatography 14, 89-92.
7. Cochereau-Massin, I., Bauchet, J., Marrakchi-Benjaafar, S., Saleh-Mghir, A., Faurisson, F., Vallois, J. M. et al. (1993). Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrobial Agents and Chemotherapy 37, 633-6.
8. Cochereau-Massin, I., Marrakchi-Benjaafar, S., Bauchet, J., Vallois, J. M., Faurisson, F., D'Hermies, F. et al. (1994). Kinetics and tolerability of intravitreal pefloxacin in rabbits. Journal of Antimicrobial Chemotherapy 33, 231-42.
9. Blondeau, J. M. (1999). Expanded activity and utility of the new fluoroquinolones: a review. Clinical Therapeutics 21, 3-40.
10. Wagstaff, A. J. & Balfour, J. A. (1997). Grepafloxacin. Drugs 53, 817-24.
11. Keren, G., Alhalel, A., Bartov, B., Kitzes-Cohen, R., Rubinstein, E., Segev, S. et al. (1991). The intravitreal penetration of orally administratered ciprofloxacin in humans. Investigative Ophthalmology and Visual Science 32, 2388-92.
12. Virgil-Alfaro, D., Hudson, S. J., Rafanan, M. M., Moss, S. T. & Levy, S. P. (1996). The effect of trauma on the ocular penetration of intravenous ciprofloxacin. American Journal of Ophthalmology 122, 678-83.
13. Gatti, G. & Panozzo, G. (1995). Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rabbits. Antimicrobial Agents and Chemotherapy 39, 549-52.
14. Ng, E. W., Samiy, N., Ruoff, K. L., Cousins, F. V., Hooper, D. C., von Gunten, S. et al. (1998). Treatment of experimental Staphylococcus epidermis endophthalmitis with oral trovafloxacin. American Journal of Ophthalmology 126, 278-87.
15. Hatano, H., Inoue, K., Shia, S. & Liping, W. (1993). Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits. Acta Ophthalmologica 71, 666-70.
16. Liu, W., Liu, Q. F., Perkins, R., Drusano, G., Louie, A. & Madu, A. (1998). Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials. Antimicrobial Agents and Chemotherapy 42, 1417-23.
17. Efthymiopoulos, C., Bramer, S. L. & Maroli, A. (1997). Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males. Clinical Pharmacokinetics 33, 1-8.
18. Efthymiopoulos, C., Bramer, S. L. & Maroli, A. (1997). Effect of age and gender on the pharmacokinetics of grepafloxacin. Clinical Pharmacokinetics 33, 9-17.
19. Efthymiopoulos, C., Bramer, S. L., Maroli, A., Flaherty, J. F., Wolfe, E., Bass, N. et al. (1997). Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction. Clinical Pharmacokinetics 33, 25-31.
20. Efthymiopoulos, C., Bramer, S. L., Maroli, A. & Gambertoglio, J. G. (1997). Effect of renal impairment on the pharmacokinetics of grepafloxacin. Clinical Pharmacokinetics 33, 32-8.
21. Perez-Olivan, S., Solans, C., Garcia, M. A., Pinilla, I., Honrubia, F. & Bregante, M. A. (2000). Determination of grepafloxacin in plasma samples by HPLC: Application to clinical pharmacokinetic studies. Chromatographia 51, 25-8.
22. Yamaoka, K., Nakagawa, T. & Uno, T. (1978). Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 6, 547-58.
23. Kozawa, O., Uematsu, T., Matsuno, H., Niva, M., Nagashima, S. & Kanamaru, M. (1996). Comparative study of pharmacokinetics of two new fluorquinolones, balofloxacin and grepafloxacin, in elderly subjects. Antimicrobial Agents and Chemotherapy 21, 2824-8.
24. Child, J., Andrews, J. M. & Wise, R. (1995). Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin. Antimicrobial Agents and Chemotherapy 39, 513-5.
25. Akiyama, H., Koike, M. & Nii, S. (1991). OPC-17116, an excellently tissue-penetrative new quinolone: pharmacokinetic profiles in animals and bacterial activities of metabolites. In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 1991. Abstract 1477, p. 345. American Society for Microbiology, Washington, DC, USA.
26. Broome, R., Brooks, D. L., Babish, J., Copeland, D. & Conzelman, G. (1991). Pharmacokinetic properties of enrofloxacin in rabbits. American Journal of Veterinary Research 52, 1835-41.
27. Drusano, G. L., Liu, W., Perkins, R., Madu, A., Madu, C. & Mayers, M. (1995). Determination of robust ocular parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program. Antimicrobial Agents and Chemotherapy 39, 1683-7.
28. Aramayona, J. J., Mora, J., Fraile, L., Garcia, M. A., Abadia, A. R. & Bregante, M. A. (1996). Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. American Journal of Veterinary Research 57, 547-53.
29. Siefert, H. M., Kohlsdofer, C., Steinke, W. & Witt, A. (1999). Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy 43, Suppl. B, 61-7.
30. Fukada, M. & Sasaki, K. (1994). Different iris coloration and uptake of a fluoroquinolone agent into the iris ciliary body of rabbit eyes. Ophthalmic Research 26, 137-40.
31. Fukada, M. & Sasaki, K. (1995). Differences between albino and pigmented rabbit eyes in the intraocular pharmacokinetics of sparfloxacin. Drugs 49, 314-6.
32. Mochizuki, K., Ohkubo, S., Torisaki, M., Yamashita, Y., Tanahashi, T. & Jin, Y. (1994). Intraocular penetration of oral levofloxacin in rabbits. Nippon Ganka Gakkai Zasshi 98, 1085-90.
33. Emiru, V. P. (1971). Response to mydriatics in the African. British Journal of Ophthalmology 55, 538-43.
34. Salazar, M., Shimada, K. & Patil, P. M. (1976). Iris pigmentation and atropine mydriasis. Journal of Pharmacology and Experimental Therapeutics 197, 79-85.
35. Zemel, E., Lowwenstein, A. Lei, B., Lazar, M. & Perlman, Y. (1995). Ocular pigmentation protects the rabbit retina from gentamicin induced toxicity. Investigative Ophthalmology and Visual Science 36, 1875-84.